These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

176 related articles for article (PubMed ID: 36096033)

  • 1. Optimal cytoreduction followed by chemoradiation in stage IVB uterine serous carcinoma.
    McEachron J; Zhou N; Hastings V; Bennett M; Gorelick C; Kanis MJ; Lee YC
    Cancer Treat Res Commun; 2022; 33():100631. PubMed ID: 36096033
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinical predictors of long-term survival for stage IVB uterine papillary serous carcinoma confined to the abdomen.
    Lee LJ; Demaria R; Berkowitz R; Matulonis U; Viswanathan AN
    Gynecol Oncol; 2014 Jan; 132(1):65-9. PubMed ID: 24211401
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Neoadjuvant chemotherapy versus primary cytoreductive surgery for stage IV uterine serous carcinoma.
    Wilkinson-Ryan I; Frolova AI; Liu J; Stewart Massad L; Thaker PH; Powell MA; Mutch DG; Hagemann AR
    Int J Gynecol Cancer; 2015 Jan; 25(1):63-8. PubMed ID: 25365590
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Uterine serous carcinoma: role of surgery, risk factors and oncologic outcomes. Experience of a tertiary center.
    Ditto A; Leone Roberti Maggiore U; Lopez S; Martinelli F; Bogani G; Lo Vullo S; Brusadelli C; Paolini B; Ducceschi M; Mantiero M; Chiappa V; Signorelli M; Evangelista M; Mariani L; Raspagliesi F
    Eur J Surg Oncol; 2022 Jan; 48(1):268-274. PubMed ID: 34753617
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Stage IVB endometrial cancer: does applying an ovarian cancer treatment paradigm result in similar outcomes? A case-control analysis.
    Landrum LM; Moore KN; Myers TK; Lanneau GS; McMeekin DS; Walker JL; Gold MA
    Gynecol Oncol; 2009 Feb; 112(2):337-41. PubMed ID: 19041126
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The influence of cytoreductive surgery on survival and morbidity in stage IVB endometrial cancer.
    Ayhan A; Taskiran C; Celik C; Yuce K; Kucukali T
    Int J Gynecol Cancer; 2002; 12(5):448-53. PubMed ID: 12366661
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Stage IVB endometrial carcinoma: the role of cytoreductive surgery and determinants of survival.
    Bristow RE; Zerbe MJ; Rosenshein NB; Grumbine FC; Montz FJ
    Gynecol Oncol; 2000 Aug; 78(2):85-91. PubMed ID: 10926785
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The role of lymphadenectomy in patients with stage III&IV uterine serous carcinoma: Results of multicentric Turkish study.
    Cakir C; Kilic F; Kilic C; Tokgozoglu N; Ersak B; Ayhan S; Akar S; Yuksel D; Korkmaz V; Boran N; Toptas T; Kimyon Comert G; Ureyen I; Tasci T; Turkmen O; Moraloglu Tekin O; Ustun Y; Turan T
    J Gynecol Obstet Hum Reprod; 2021 May; 50(5):102063. PubMed ID: 33453448
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Survival impact of cytoreduction to microscopic disease for advanced stage cancer of the uterine corpus: a retrospective cohort study.
    Alagkiozidis I; Grossman A; Tang NZ; Weedon J; Mize B; Salame G; Lee YC; Abulafia O
    Int J Surg; 2015 Feb; 14():61-6. PubMed ID: 25576762
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Multimodality adjuvant therapy and survival outcomes in stage I-IV uterine carcinosarcoma.
    McEachron J; Heyman T; Shanahan L; Tran V; Friedman M; Gorelick C; Economos K; Singhal PK; Lee YC; Kanis MJ
    Int J Gynecol Cancer; 2020 Jul; 30(7):1012-1017. PubMed ID: 32447295
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The role of cytoreductive surgery in the management of stage IV uterine papillary serous carcinoma.
    Bristow RE; Duska LR; Montz FJ
    Gynecol Oncol; 2001 Apr; 81(1):92-9. PubMed ID: 11277657
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Survival Dynamics in Advanced Ovarian Cancer: R2 Resection Versus No-Surgery Paths Explored.
    Pitsikakis K; DeJong D; Kitsos-Kalyvianakis K; Mamalis ME; Quaranta M; Shavee A; Wahab A; Thangavelu A; Broadhead T; Nugent D; Kalampokis E; Laios A
    Cancer Control; 2024; 31():10732748241285480. PubMed ID: 39283489
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evaluation of the optimal sequence of adjuvant chemotherapy and radiation therapy in the treatment of advanced endometrial cancer.
    McEachron J; Zhou N; Spencer C; Shanahan L; Chatterton C; Singhal P; Lee YC
    J Gynecol Oncol; 2020 Nov; 31(6):e90. PubMed ID: 33078595
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Neoadjuvant chemotherapy in patients with stage IVB uterine serous carcinoma: a Turkish multicentric study.
    Unsal M; Kilic C; Cakir C; Kilic F; Ersak B; Karakas S; Tokgozoglu N; Varli B; Oktar O; Kimyon Comert G; Ozdemir IA; Boran N; Toptas T; Ureyen I; Korkmaz V; Taskin S; Moraloglu Tekin O; Ustun Y; Tasci T; Ortac F; Turan T
    J Obstet Gynaecol; 2023 Dec; 43(1):2151355. PubMed ID: 36503383
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Improved survival with combination chemotherapy and external beam radiation therapy in uterine carcinosarcoma.
    McEachron J; Chen YJ; Zhou N; Kao J; Gorelick C; Kanis MJ; Lee YC
    Int J Gynecol Cancer; 2022 Nov; 32(11):1402-1409. PubMed ID: 36343971
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prognostic determinants in patients with stage IIIC and IV uterine papillary serous carcinoma.
    Rauh-Hain JA; Growdon WB; Schorge JO; Goodman AK; Boruta DM; McCann C; Horowitz NS; del Carmen MG
    Gynecol Oncol; 2010 Nov; 119(2):299-304. PubMed ID: 20691465
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The role of multi-modality adjuvant chemotherapy and radiation in women with advanced stage endometrial cancer.
    Alvarez Secord A; Havrilesky LJ; Bae-Jump V; Chin J; Calingaert B; Bland A; Rutledge TL; Berchuck A; Clarke-Pearson DL; Gehrig PA
    Gynecol Oncol; 2007 Nov; 107(2):285-91. PubMed ID: 17688923
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Potential risk factors associated with prognosis of neoadjuvant chemotherapy followed by interval debulking surgery in stage IIIc-IV high-grade serous ovarian carcinoma patients.
    Zhang J; Liu N; Zhang A; Bao X
    J Obstet Gynaecol Res; 2018 Sep; 44(9):1808-1816. PubMed ID: 30019801
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Uterine serous carcinoma: Reassessing effectiveness of platinum-based adjuvant therapy.
    Tortorella L; Langstraat CL; Weaver AL; McGree ME; Bakkum-Gamez JN; Dowdy SC; Cliby WA; Keeney GL; Sherman ME; Weroha SJ; Mariani A; Podratz KC
    Gynecol Oncol; 2018 May; 149(2):291-296. PubMed ID: 29550183
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Analysis of factors related to the prognostic benefit of neoadjuvant chemotherapy followed by interval debulking surgery in patients with advanced ovarian cancer].
    Wang DF; Zhang GN; Peng CR; Shi Y; Shi XW
    Zhonghua Fu Chan Ke Za Zhi; 2021 Jun; 56(6):385-392. PubMed ID: 34154313
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.